Might B-type natriuretic peptide (BNP) become a routine measure in the care of patients with heart failure?
The article raises the question of whether BNP will become a routine diagnostic and monitoring tool for heart failure, akin to thyroid function tests for hypothyroidism.
BNP: soon to become a routine measure in the care of patients with heart failure? Clinicians are increasingly using biochemical markers of disease to help diagnose and monitor disease states. Might B-type natriuretic peptide (BNP) become the same to heart failure as thyroid function tests are to hypothyroidism?
Martín Cowie (2000) studied this question.